18 nov. 2020 The aggregate market value of the voting common shares held by non-affiliates ... any new issuances under the Organogenesis Inc. 2003 Stock ...
NASDAQ ORGO c a ce ed e
17 nov. 2020 closing sale price of the Class A common stock as reported by The Nasdaq Capital Market on June 30 2021
15 mars 2007 These investors allegedly lost money after purchasing the common stock of. Organogenesis during the proposed class period of November 15 ...
ClassCertificationDenied
10 nov. 2020 We are offering 17500
1 mars 2022 closing sale price of the Class A common stock as reported by The Nasdaq Capital Market on June 30 2021
9 mars 2020 The aggregate market value of the voting common shares held by non-affiliates of the registrant was approximately $48.4 million computed by.
NASDAQ ORGO
its underwritten public offering of 16741
14 janv. 2019 common stock issued to the executive officers of Organogenesis in connection with the merger; (vi) 378281 shares of Class A common stock ...
19 oct. 2007 Tumorigenesis and organogenesis share similar steps including ... Known cancer genes and lung organogenesis. The organogenesis.
18 mars 2019 sale price of the common stock as reported by The Nasdaq Capital ... Organogenesis is a leading regenerative medicine company focused on the ...
NASDAQ ORGO